je.st
news
Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data
2015-03-04 04:49:19| drugdiscoveryonline Home Page
DSG, Inc and Sirion Therapeutics collaborated in launching the industry’s first two pivotal Phase 3 studies using entirely electronic source data collection for the safety and efficacy of Difluprednate in the management of inflammation following ocular surgery
Tags: data
source
fully
studies
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||